<code id='BDCE958245'></code><style id='BDCE958245'></style>
    • <acronym id='BDCE958245'></acronym>
      <center id='BDCE958245'><center id='BDCE958245'><tfoot id='BDCE958245'></tfoot></center><abbr id='BDCE958245'><dir id='BDCE958245'><tfoot id='BDCE958245'></tfoot><noframes id='BDCE958245'>

    • <optgroup id='BDCE958245'><strike id='BDCE958245'><sup id='BDCE958245'></sup></strike><code id='BDCE958245'></code></optgroup>
        1. <b id='BDCE958245'><label id='BDCE958245'><select id='BDCE958245'><dt id='BDCE958245'><span id='BDCE958245'></span></dt></select></label></b><u id='BDCE958245'></u>
          <i id='BDCE958245'><strike id='BDCE958245'><tt id='BDCE958245'><pre id='BDCE958245'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:687
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Doctors on social media are being harassed and cyberbullied
          Doctors on social media are being harassed and cyberbullied

          AdobeAswomeninmedicinewhousesocialmediatoadvocateforpublichealthandsocialjustice,weknowfirsthandwhat

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk